A world-renowned leader in oncology. He currently serves as Distinguished Professor and Physician-in-Chief Emeritus at the Translational Genomics Research Institute (TGen) and formerly served as Professor of Medicine and Medical Oncologist at Mayo Clinic (Scottsdale, Arizona) and held the Piper Distinguished Chair for Innovative Cancer Research at Honor Health Research Institute.
Dr. Von Hoff has led numerous clinical trials in oncology drug development and translational medicine. He has made pivotal contributions to the advancement of pancreatic cancer treatment, with a longstanding commitment to translating basic scientific discoveries into clinical treatment strategies. His work played a key role in establishing gemcitabine as one of the standard first-line therapies for pancreatic cancer, significantly influencing global treatment practice and earning him international recognition in oncology and anticancer drug development.
Dr. Von Hoff has led numerous clinical trials in oncology drug development and translational medicine. He has made pivotal contributions to the advancement of pancreatic cancer therapy, with a longstanding commitment to translating basic scientific discoveries into clinical treatment strategies. His work played a key role in establishing gemcitabine as one of the standard first-line therapies for pancreatic cancer, significantly influencing global clinical practice and earning him international recognition in oncology and anticancer drug development.
Dr. Yiu-Lian Fong PhD, MBA
The former Global Head, Diagnostic Innovation and R&D and Clinical Biomarker Strategy and Development at Janssen, Johnson & Johnson
The former Vice President of R&D in Abbott's Molecular Diagnostic Division
The former Director of R&D for Novartis Vaccine and Drug Development, and the Executive Director at the Novartis Molecular Diagnostics and the Novartis Oncology Division for Drug and Companion Diagnostic co-development
The expert consultant of the Ministry of Science and Technology Council
The expert consultant of the Bio Taiwan Committee (BTC) under the Executive Yuan
The committee member of BTC since 2000
Dr. Mann Fung, M.D., MBA, MHCM, FACP
Former Global Vice President, Janssen Pharmaceuticals (Johnson & Johnson)
Japan Head, Multinational Business Division, Eli Lilly and Company.
Medical Officer, Center for Drug Evaluation and Research (CDER),U.S. Food and Drug Administration (FDA).
Doctor of Medicine, University of Utah.
Master of Business Administration in Healthcare Management, Harvard University.
Min-Chun Chen, MD MPH
Currently Senior Staff Physician and Clinical Faculty in Internal Medicine and Hematology-Medical Oncology at MultiCare Regional Cancer Center affiliated with UW Med and Fred Hutchinson Cancer Center (FHCC)
Dr. Chen Graduated from Taipei Medical College (TMC), now Taipei Medical University (TMU), in 1981; He studied at and obtained a MPH Degree from the University of Texas (UT) Health Sciences Center at Houston in 1984.
He has written and published more than 15 peer-reviewed journal articles and text-book chapters in the fields of Medical Oncology and Hematology from 1989 through 2017.